Soof Solutions

Operating

Soof Solutions Inc.

Software & AI · Alameda, CA

Soof Solutions is developing an App-based eye-tracking communication suite for stroke and ALS patients, currently in early pilot programs with initial users in healthcare and assisted-care settings.

Valuation cap ⓘ

$12.0M

As of Jun 2026 · from Reg CF Offering (2026) · a SAFE/note conversion ceiling, not a priced valuation

Total raised

$45,556

Across 1 round since 2026

Financials

FY2023–FY2024 · from SEC filings · hover any figure for its source

−$66K

2023

−$43K

2024

RevenueNet income — beside revenue when positive, below the line when a loss

Metric

FY2023 reviewed

FY2024 reviewed

Income statement

Revenue

Cost of goods sold

Net income

-$66,306

-$42,633

Taxes paid

Balance sheet

Cash

$31,996

$34,523

Accounts receivable

Total assets

$35,997

$34,523

Short-term debt

$55,192

$56,346

Long-term debt

Total liabilities

$55,192

$56,346

Other

Headcount

—

Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited, as the filing’s own report or certification states it. A dashed pill marked * is inferred instead: the SEC minimum for an offering that size, which the issuer may have exceeded. No pill means we couldn’t tell. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.

Valuation over rounds

Valuation caps on SAFE / convertible note rounds

$12.0M

Valuation cap

Reg CF · SAFE · Feb 2026

Dashed amber bars are a SAFE or convertible note's valuation cap — the most it converts at, not what the company is worth.

Fundraising history

Reg CF · SAFE · Feb 2026Closedvia StartEngine

Raised $45.6K / $1.2MInvestors 26Valuation cap $12M

Team

4 people

Maheen Mausoof Adamson, PhD, MHLFounder

CEO, Founder and principal accounting officer

Clinical Associate Professor (Affiliated) at Stanford Medicine and Research Director at VA Palo Alto. A neuroscientist with deep expertise in neurorehabilitation.

Toby Barrack, MD, MBA

COO

Combines medical background with business acumen to drive operational strategy, clinical partnerships, and scalable growth.

Ibrahim A. Samad

Head of Growth

Visionary Growth Architect and ex-FMCG/D2C veteran. Specializes in ROI-driven performance and operational excellence to define market leadership.

Katherine Reese, MA, CCC-SLP

Lead Speech Pathologist

Ensures clinical validity and product efficacy for aphasia and stroke rehabilitation.

Names and titles as disclosed on SEC Form C, StartEngine. Bios and photos come from the platform campaign page and may be out of date.

Reg CF annual-report compliance

Delinquent

Filed 0 of 1 annual reports (FY2025)

Missing: 2025

26 investors

holder-count proxy

Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.

SEC filings

Form C-UJul 1, 20260002097299-26-000006
EDGAR
Form C/AApr 24, 20260002097299-26-000005
EDGAR
Form CFeb 5, 20260002097299-26-000002
EDGAR

Source: SEC EDGARCIK 0002097299DELast synced Aug 17, 2026

About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.